AskBorsa
ARSign up free
EGX·Health Care & Pharmaceuticals

Medical Packaging

MEPA
Fiscal year starts in January · currency EGP · latest: Q2 2026
Next results: Q3 2026 — expected around 16 November 2026published last year on 16 November 2025Results calendar ←
1.26EGP+2.44% today1w +0.8%1m −30.0%delayed · 3 November
Net profit · 2024
36.58million
▲ 73.3% vs 2023
Total assets · 2024
233million
▲ 23.0% vs 2023
Shareholders' equity · 2024
195million
▲ 20.7% vs 2023
Operating cash flow · 2024
24.15million
▲ 251.8% vs 2023

Key facts

Source: annual statements 2024
  • Medical Packaging's net profit in 2024 was 36.58 million EGP, up 73.3% from 21.1 million EGP in 2023.
  • Total assets at the end of 2024 were 233 million EGP, and shareholders' equity 195 million EGP.
  • Operating cash flow in 2024 was positive at 24.15 million EGP.

Medical Packaging's Q3 2026 results are expected around 16 November — we email you the day they land

One email on the day, no account, and a one-click stop in the email itself.

orFollow on TelegramEvery result as it lands, in the @askborsa channel

By subscribing you agree to receive these alerts only. Privacy policy

AI summary

Preparing a summary of the latest results…

Ask about Medical Packaging
How much did Medical Packaging's net profit grow last year?What were total assets and shareholders' equity in the latest annual balance sheet?Was operating cash flow positive in the last three years?Type your question…Ask
3 free questions a day after signing up. With Google, no password.
Annual net profit last 5 years
Net profit
4.41million
7.68million
−2.36million
21.1million
36.58million
20202021202220232024

Summarised financial statements

Excel · Pro
Swipe the table to see the other years.
Item · EGP20202021202220232024
Income statement
Net profit4.41 million7.68 million-2.36 million21.1 million36.58 million
Gross profit14.01 million17.52 million24.26 million48.66 million57.32 million
Total assets107 million107 million121 million190 million233 million
Total liabilities42.09 million34.2 million42.5 million28 million38.05 million
Shareholders' equity65.35 million73.02 million78.76 million162 million195 million
Total liabilities and equity107 million107 million121 million190 million233 million
Operating cash flow2.3 million10.48 million24.64 million6.86 million24.15 million
Investing cash flow-230 thousand-472 thousand-229 thousand-252 thousand-15.8 million
Financing cash flow-2.66 million-10.06 million-5 million29.52 million33.4 million
Net change in cash-587 thousand-53.52 thousand10.96 million36.14 million41.75 million
Sign up free to see the full five years for every period.
Sign up free in seconds
With Google or your email, no password.

Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. What does this line mean?

Results by period

One page per period: the figures against the same period a year earlier, and the official report.

Q2 2025Q1 2025Fiscal year 2024Q4 2024Q3 2024Q2 2024Q1 2024Fiscal year 2023Q4 2023Q3 2023Q2 2023Q1 2023Fiscal year 2022Q4 2022Q3 2022Q2 2022Q1 2022Fiscal year 2021Fiscal year 2020

Financial reports (16)

2026Q2
PDF
2026Q1
PDF
2025Q2
PDF
2025Q1
PDF
2025Annual
PDF
2025Q3
PDF
2024Q3
PDF
2024Q2
PDF
2023Annual
PDF
2023Q3
PDF
2023Q2
PDF
2022Q1
PDF
2022Q2
PDF
2022Q3
PDF
2021Annual
PDF
2020Annual
PDF

Other companies in Health Care & Pharmaceuticals

Ranked by latest annual net profit
All companies in the sector ←
EIPICOPHAR·1.1billion+33%Ibnsina PharmaISPH·952million+55%Cleopatra Hospitals GroupCLHO·824million+14%Alexandria PharmaceuticalsAXPH·660million+1132%Memphis PharmaceuticalsMPCI·480million−5%Cairo PharmaceuticalsCPCI·444million+769%